Singer DE - Search Results

1

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.

Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Hylek EM, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators. Inohara T, et al. Among authors: singer de. Heart. 2020 Mar;106(5):358-364. doi: 10.1136/heartjnl-2019-315792. Epub 2020 Jan 7. Heart. 2020. PMID: 31911503

2

The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.

Singer DE, Hughes RA, Gress DR, Sheehan MA, Oertel LB, Maraventano SW, Blewett DR, Rosner B, Kistler JP. Singer DE, et al. Am Heart J. 1992 Dec;124(6):1567-73. doi: 10.1016/0002-8703(92)90074-6. Am Heart J. 1992. PMID: 1462916 Clinical Trial.

3

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Lancaster TR, Singer DE, Sheehan MA, Oertel LB, Maraventano SW, Hughes RA, Kistler JP. Lancaster TR, et al. Among authors: singer de. Arch Intern Med. 1991 Oct;151(10):1944-9. Arch Intern Med. 1991. PMID: 1929681 Clinical Trial.

4

Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

Singer DE, Hylek EM. Singer DE, et al. N Engl J Med. 1995 Nov 30;333(22):1504. doi: 10.1056/NEJM199511303332213. N Engl J Med. 1995. PMID: 7477157 No abstract available.

5

Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Hylek EM, Singer DE. Hylek EM, et al. Among authors: singer de. Ann Intern Med. 1994 Jun 1;120(11):897-902. doi: 10.7326/0003-4819-120-11-199406010-00001. Ann Intern Med. 1994. PMID: 8172435

6

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Hylek EM, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. Among authors: singer de. N Engl J Med. 1996 Aug 22;335(8):540-6. doi: 10.1056/NEJM199608223350802. N Engl J Med. 1996. PMID: 8678931 Free article.

7

Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.

Singer DE. Singer DE. Proc Assoc Am Physicians. 1996 Jan;108(1):29-36. Proc Assoc Am Physicians. 1996. PMID: 8834062 Review.

8

Preventing stroke in atrial fibrillation.

Wolf PA, Singer DE. Wolf PA, et al. Among authors: singer de. Am Fam Physician. 1997 Dec;56(9):2242-50. Am Fam Physician. 1997. PMID: 9402810 Review.

9

Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. Among authors: singer de. JAMA. 1998 Mar 4;279(9):657-62. doi: 10.1001/jama.279.9.657. JAMA. 1998. PMID: 9496982

10

Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care.

Singer DE. Singer DE. Am J Cardiol. 1998 Mar 12;81(5A):35C-40C. doi: 10.1016/s0002-9149(98)00185-4. Am J Cardiol. 1998. PMID: 9525571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters